Relay Therapeutics (RLAY) Other Gross PP&E Adjustments: 2020-2025
Historic Other Gross PP&E Adjustments for Relay Therapeutics (RLAY) over the last 6 years, with Sep 2025 value amounting to -$41.7 million.
- Relay Therapeutics' Other Gross PP&E Adjustments rose 21.91% to -$41.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$168.4 million, marking a year-over-year increase of 18.93%. This contributed to the annual value of -$33.8 million for FY2024, which is 21.20% up from last year.
- Per Relay Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at -$41.7 million for Q3 2025, which was up 2.48% from -$42.7 million recorded in Q2 2025.
- In the past 5 years, Relay Therapeutics' Other Gross PP&E Adjustments ranged from a high of -$8.2 million in Q4 2021 and a low of -$65.2 million during Q3 2022.
- Over the past 3 years, Relay Therapeutics' median Other Gross PP&E Adjustments value was -$53.4 million (recorded in 2024), while the average stood at -$50.8 million.
- Per our database at Business Quant, Relay Therapeutics' Other Gross PP&E Adjustments slumped by 485.16% in 2022 and then grew by 22.20% in 2025.
- Relay Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at -$8.2 million in 2021, then tumbled by 485.16% to -$48.2 million in 2022, then rose by 11.00% to -$42.9 million in 2023, then climbed by 21.20% to -$33.8 million in 2024, then climbed by 21.91% to -$41.7 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$41.7 million for Q3 2025, versus -$42.7 million for Q2 2025 and -$50.1 million for Q1 2025.